JUSTIN MCGINNIS: Open Payments
NPI 1497234769 · FLEMING ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 45 payments from 9 companies in 2025. Trend: 2023 $369 · 2024 $1,499 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $332 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $217 |
| Boston Scientific Corporation | 4 | $171 |
| Saluda Medical Americas, Inc. | 6 | $162 |
| Medtronic, Inc. | 1 | $96 |
| PFIZER INC. | 2 | $33 |
| Globus Medical, Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $30 |
| Abbott Laboratories | 1 | $19 |
Products named: RELISTOR, QULIPTA, Intracept, Evoke, SYNCHROMEDII, UBRELVY, NURTEC ODT, Vyrsa V1.
Industry payments across FL — which companies pay providers there.
